-
Mashup Score: 32Predicting CKD Outcomes in Lupus Nephritis | RheumNow - 2 day(s) ago
An observational cohort study suggests that proteinuria levels in lupus nephritis (LN) patients did not predict their histologic class. A multicentre observational study of patients with biopsy-proven LN; either proliferative (PLN) or membranous (MLN) lupus nephritis were compared regarding clinical and laboratory presentation and long-term outcomes. The primary outcome was progression to chronic kidney disease (CKD).
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3Chào: (Vietnamese: Goodbye/Hello) | RheumNow - 3 day(s) ago
One of the first words I was taught by my parents was “chào”. In Vietnamese, you say chào and bow when you greet someone or when you leave as a sign of respect. In my first blog about self-discovery, I detailed the burnout and why I left clinical practice. In this second blog of the trilogy, I wanted to share encounters with patients as I told them goodbye. While I received great advice when I started practice, no one ever talks about how hard it is to leave.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0ICYMI: Five Takeaways in PsA/SpA at RNL 2024 | RheumNow - 3 day(s) ago
Continuing with the theme of clinical pearls, the PsA and SpA speakers also provided a wealth of information. Here are my five key takeaways and clinical pearls.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 8Self Acupressure in Knee Osteoarthritis | RheumNow - 4 day(s) ago
A clinical trial has shown that self-administered acupressure (SAA) is effective in relieving knee osteoarthritis (KOA) patients.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 14ICYMI: How do you manage enthesitis? | RheumNow - 4 day(s) ago
Enthesitis can be a challenge for clinicians to identify, evaluate, and manage in patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). It affects 27-35% of PsA patients and 36% of axSpA patients. Dr. Lihi Eder discussed the evaluation and treatment of enthesitis at RheumNow Live on January 28, 2024.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Canary in a Coal Mine (4.19.2024) | RheumNow - 4 day(s) ago
Dr. Jack Cush reviews regulatory reports, news and novel journal articles – this week focusing on Sjogren’s, ILD, Gout and Uveitis.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 8
A population-based cohort has demonstrated that sodium-glucose cotransporter-2 inhibitors (SGLT2i) use in gout patients is superior to sulfonylurea therapy in lowering the risk of incident gout and recurrent flares among patients with type 2 diabetes (T2D).
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 63BSR Guideline on Management of Sjogren’s Syndrome | RheumNow - 6 day(s) ago
Sjögren disease (SD) is the most common of all autoimmune disease, yet little is know of its etiology and there are insufficent interventions for those affected with mucosal or systemic manifestations. The British Society of Rheumatology has updated its 2017 guidelines, with wider evidence and recommendations for the management of children and adolescents with SD. This article reviews the data and recommendations stemming from 19 questions on SD care. An abbreviated version of these Questions and recommendations are provided below.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11ILD Onset in MDA-5 Dermatomyositis | RheumNow - 7 day(s) ago
Anti–melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM) is a rare, aggressive and progressive subtype of DM. Its’ severity is dependent on the development of progressive interstitial lung disease (ILD), manifesting as either rapidly progressive ILD (RPILD) and chronic ILD (CILD). MDA-5+ RPILD carries a high mortality rate and defined by worsening dyspnea accompanied by radiographic changes within 3 months of pulmonary symptom onset. The reported study defines the time interval between ILD and MDA5+ DM diagnosis.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2
A prospective, multicenter study from Spain has demonstrated higher rates of mortality and serious infection in rheumatoid arthritis–associated interstitial lung disease (RA-ILD) patients.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
Predicting CKD Outcomes in Lupus Nephritis An observational cohort study suggests that proteinuria levels in lupus nephritis (LN) patients did not predict their histologic class. https://t.co/SCsuYuXgw4 https://t.co/bHB9ggf20H